Purchase Order AG2349P170013

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to O.d.260, Inc., a for-profit Subchapter S Corporation, for Adenoviral (adenovirus) amplification, purification, and titer determination services. The contract has a ceiling value of $7,636.00 and a completion date of December 21, 2018. This award does not appear to be associated with a larger contract...

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Government Scientific Source Inc., a prime contractor, for the supply of 4,565,384,830 units of adenovirus reagent (2 ml). The contract has a ceiling value of $3,958.09 and is a fixed-price contract with an economic price adjustment. The period of performance runs from the award date of August 7, 2024 to the ultimate completion date of August 28, 2024. The contract does not have a set-aside designation. Government...

This federal contract award is for SBIR Phase III research under Topic A14-045 "Modernized Production Adenovirus Vaccine (MPAV)" for the Department of the Army Medical Command. The prime contractor is Emergent Travel Health Inc., a for-profit biopharmaceutical company that specializes in vaccine development and production. The contract is a definitive, cost-no-fee contract with a potential value of $652,166.39. The work is being performed at Emergent's facility in Redwood City,...

This is a $699,058.35 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Barr Laboratories, Inc., a for-profit manufacturer of medical goods. The contract is for the delivery of adenovirus type 4, a virus that causes respiratory illness. This delivery order was awarded on August 11, 2017 with a completion date of August 29, 2017. The contract does not have a set-aside designation. Barr Laboratories, Inc. is the prime contractor and is...

This federal contract award, identified as HHSN272201400873P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $7,335.00 firm-fixed-price purchase order was awarded to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products, to provide 15 units of AMBIS 1695546 PLASMID PREP, 3MG, CAT # 3000, at a...

This firm fixed-price purchase order for $9,150.00 was awarded to DNA Twopointo Inc. (doing business as ATUM Biosciences) by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to provide other functions related to adenovirus vector construction. The award does not have a set-aside designation. DNA Twopointo Inc. is a for-profit manufacturer that has previously received federal contracts and grants from various agencies, including NIAID, the Naval Sea Systems...

This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...

This is a $163,682 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services (HHS), to Genewiz, LLC, a subsidiary of Azenta, Inc. (doing business as Brooks). The contract is for the rapid development of candidate vaccine viruses, with a completion date of December 31, 2020. Genewiz has provided DNA and RNA sequencing, gene synthesis, and other genomic services to various federal agencies under past...

<p>This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Barr Laboratories, Inc., a for-profit manufacturer of medical goods. The $570,530.16 contract is for the delivery of Adenovirus Type 4, which is used to treat respiratory illness. The contract has a completion date of June 26, 2018 and was awarded on June 14, 2018. This award is not associated with a larger contract vehicle and does not have a set-aside designation.</p>

<p>This is a delivery order awarded by the Defense Logistics Agency Troop Support Medical to Barr Laboratories, Inc., a for-profit manufacturer, for the provision of Adenovirus Type 4 A, a virus that causes respiratory illness. The contract has a firm fixed price, has no set-aside designation, and was awarded on June 9, 2017 with a completion date of June 20, 2017. The potential value of this contract is $139,811.67. Barr Laboratories, Inc. is the prime contractor for this delivery order.</p>